MCE Conferences Dermatology and Women’s Health for Primary Care Jul 10, 2026 – Jul 12, 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Primary Care Physicians, Dermatologists, and Gynecologists

+ Sample video: contact me for sample video

+ Information:

The “Dermatology and Women’s Health for Primary Care” conference is a 12-credit continuing medical education event scheduled for July 10-12, 2026, at the Lido Beach Resort in Lido Key, Sarasota, Florida. This conference is designed to provide primary care practitioners with up-to-date, evidence-based information on commonly encountered issues in Dermatology and Women’s Health, while suggesting pragmatic approaches to clinical management. The discussion-based format encourages audience participation through dynamic lectures, case-based studies, and hands-on workshops, with the ultimate goal of improving patient outcomes through effective diagnosis and treatment.

Learning Objectives

Upon completion of this program, participants should be better able to:

• Diagnose common benign and malignant skin neoplasms, select proper destructive methods, and determine optimal approaches, including specialty referral.

• Describe the role of long-acting reversible contraception (LARC), optimize combination contraceptive prescribing, and identify emergency contraception options.

• Discuss cardiovascular risks and benefits of Menopausal Hormone Therapy (MHT), summarize evidence on breast cancer risk, and identify current prescribing best practices.

• Describe the natural history of HPV infection, identify current Pap testing guidelines, and understand the role of HPV testing in detecting cervical neoplasia.

• Discuss the roles and limitations of vaginitis diagnostic tests, manage persistent/resistant vaginitis, and identify other entities causing vaginal symptoms.

• Clinically differentiate acne from rosacea, identify etiology differences, and employ proper treatments for both.

• Recognize cutaneous signs of internal malignancy and enhance awareness of cutaneous metastatic disease.

• Classify itchy patients into clinical groups, recognize what to look for when evaluating pruritus, and manage the symptom of itch.

• Recognize how common diseases appear differently in skin of color, manage unique skin diseases in this population, and understand the effects of cultural and medical practices.

• Describe the pathophysiology of Polycystic Ovary Syndrome (PCOS) and identify management options for its gynecologic and metabolic consequences.

• Describe the normal female sexual response model, identify diagnostic categories and etiologies for female sexual dysfunction, and discuss management options.

Target Audience

• All Physicians and other Healthcare Professionals seeking clinical information about issues in Dermatology and Women’s Health. Best for Primary Care Physicians, Dermatologists, and Gynecologists.

Topics

• Benign Skin Tumors: Diagnose common benign skin neoplasms; Select proper destructive methods to eliminate benign skin tumors; Recognize serious systemic associations with benign skin neoplasms.

• Malignant Skin Tumors: Diagnose the common malignant skin tumors; Determine the optimal approach to malignant skin tumors; Select cases that should be referred to specialty care.

• Contraception 2026: Describe the role of long-acting reversible contraception (LARC) in family planning; Discuss risks, benefits and counseling guidelines for long-acting methods; Discuss optimal prescribing of combination contraceptives, such as the pill, patch, and ring; Identify the available options for emergency contraception, including the benefits and limitations.

• Menopausal Hormone Therapy 2026: Discuss data on the cardiovascular risks and benefits of MHT generated after the initial publication from the Women’s Health Initiative; Summarize current evidence regarding the effect of MHT on breast cancer risk; Identify current best practices for prescribing MHT.

• Evolving Guidelines for Pap and HPV Testing: Describe the natural history of HPV infection and how it relates to current screening recommendations for cervical neoplasia; Identify current guidelines for frequency of Pap testing; Describe the role of HPV testing in detecting cervical neoplasia.

• Vaginitis: Tackling the Tough Cases: Discuss the roles for, and limitations of, the tests currently available for the diagnosis of vaginal infections; Describe current recommendations and options for managing persistent and resistant vaginitis; Identify entities, other than vaginitis, that may be associated with vaginal symptoms.

• Acne/Rosacea Primer: Clinically differentiate acne from rosacea; Identify differences in etiology between acne and rosacea; Employ proper treatments for both acne and rosacea.

• Cutaneous Signs of Internal Malignancy: Recognize criteria for skin findings to be signs of internal malignancy; Identify the most common cutaneous signs of internal malignancy; Enhance awareness of cutaneous metastatic disease.

• The Itchy Patient: Classify itchy patients into clinical groups, which suggest etiology; Recognize where to look and what to look for when patients present with pruritus; Manage the symptom of itch.

• Skin Disease in Skin of Color: Recognize how common diseases may appear differently in skin of color patients; Identify and manage select skin diseases more common or unique to skin of color patients; Discuss effects of cultural and medical practices on skin disease in skin of color patients.

• Polycystic Ovary Syndrome Simplified (Polyendocrine Metabolic Ovarian Syndrome): Describe the proposed pathophysiology of polycystic ovary syndrome; Identify management options for the gynecologic consequences of polycystic ovary syndrome, such as irregular menses, hirsutism, and infertility; Identify management options for the metabolic effects of polycystic ovary syndrome.

• Female Sexual Dysfunction: Describe the current model of normal female sexual response; Identify the diagnostic categories for female sexual dysfunction and discuss possible etiologies for each; Discuss management options for each category of female sexual dysfunction.